Skip to content
2000
Volume 23, Issue 1
  • ISSN: 1570-1638
  • E-ISSN: 1875-6220

Abstract

Chromothripsis, a phenomenon of massive genomic rearrangements, introduces extensive mutations in critical genes, affecting cell survival and apoptosis. Among these genes, the BCL-2 (B-cell lymphoma 2) gene, which plays a crucial antiapoptotic role in cancer cells, is often subjected to significant alterations. Here, we present a computational pipeline to model and analyze the structural and functional impacts of chromothripsis-induced Single-Nucleotide Polymorphisms (SNPs) within the BCL-2 gene. This pipeline integrates mutation simulation, homology modeling, and protein interaction analysis to evaluate the stability and apoptotic potential of BCL-2 mutations. These results indicate that chromothripsis-induced mutations can destabilize the BCL-2 protein, thereby disrupting its binding affinity with apoptotic regulators, such as Bax. These findings support the potential of ergodic anticancer therapy to exploit such mutations, facilitating the apoptosis of cancer cells. Our computational model offers a novel approach for understanding mutation-driven alterations in cancer biology, aiding the development of therapeutic strategies targeting apoptotic pathways.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cddt/10.2174/0115701638381646250523115445
2025-06-02
2026-03-07

  • From This Site

    /content/journals/cddt/10.2174/0115701638381646250523115445
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PellestorF. Chromoanagenesis: Cataclysms behind complex chromosomal rearrangements.Mol. Cytogenet.2019121610.1186/s13039‑019‑0415‑7 30805029
     [Google Scholar]
  2. PellestorF. GaillardJ.B. SchneiderA. PuechbertyJ. GatinoisV. Chromoanagenesis, the mechanisms of a genomic chaos.Semin. Cell Dev. Biol.2022123909910.1016/j.semcdb.2021.01.004 33608210
     [Google Scholar]
  3. ShityakovS. KravtsovV. SkorbE.V. NosonovskyM. Ergodicity breaking and self-destruction of cancer cells by induced genome chaos.Entropy20232613710.3390/e26010037 38248163
     [Google Scholar]
  4. BrierleyC.K. SteensmaD.P. ShachamS. BCL-2 as a therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.Blood Rev.202358100997
     [Google Scholar]
  5. FareedM.M. DuttaK. DandekarT. TarabondaH. SkorbE.V. ShityakovS. In silico investigation of nonsynonymous single nucleotide polymorphisms in BCL-2 apoptosis regulator gene to design novel protein‐based drugs against cancer.J. Cell. Biochem.2022123122044205610.1002/jcb.30330 36146908
     [Google Scholar]
  6. ShorokhovaM. NikolskyN. GrinchukT. Chromothripsis—explosion in genetic science.Cells2021105110210.3390/cells10051102 34064429
     [Google Scholar]
  7. NosonovskyM. RoyP. Allometric scaling law and ergodicity breaking in the vascular system.Microfluid. Nanofluidics20202475310.1007/s10404‑020‑02359‑x
     [Google Scholar]
  8. HengH.H.Q. StevensJ.B. LiuG. Stochastic cancer progression driven by non‐clonal chromosome aberrations.J. Cell. Physiol.2006208246147210.1002/jcp.20685 16688757
     [Google Scholar]
  9. HengH.H. Genome chaos: Rethinking genetics, evolution, and molecular medicine. cambridge.MA, USAAcademic Press Elsevier2019
     [Google Scholar]
  10. RoccoA. KierzekA.M. McFaddenJ. Slow protein fluctuations explain the emergence of growth phenotypes and persistence in clonal bacterial populations.PLoS One201381e5427210.1371/journal.pone.0054272 23382887
     [Google Scholar]
  11. ZhangC.Z. LeibowitzM.L. PellmanD. Chromothripsis and beyond: Rapid genome evolution from complex chromosomal rearrangements.Genes Dev.201327232513253010.1101/gad.229559.113 24298051
     [Google Scholar]
  12. PootM. Of simple and complex genome rearrangements, chromothripsis, chromoanasynthesis, and chromosome chaos.Mol. Syndromol.20178311511710.1159/000454964 28588432
     [Google Scholar]
  13. ShityakovS. Perspectives on ergodic cancer therapy derived from cloning genome chaos via in vivo rhabdomyosarcoma RA-2 models: A narrative review.Curr. Cancer Drug Targets202410.2174/0115680096319768241003060636
     [Google Scholar]
  14. GovindS.K. ZiaA. Hennings-YeomansP.H. ShatterProof: Operational detection and quantification of chromothripsis.BMC Bioinformatics20141517810.1186/1471‑2105‑15‑78 24646301
     [Google Scholar]
  15. YangJ. DengG. CaiH. ChromothripsisD.B. A curated database of chromothripsis.Bioinformatics20163291433143510.1093/bioinformatics/btv757 26722116
     [Google Scholar]
  16. CaiH. ChromothripsisD.B. A curated database for the documentation, visualization, and mining of chromothripsis data.Methods Mol. Biol.2018176927928910.1007/978‑1‑4939‑7780‑2_18 29564831
     [Google Scholar]
  17. Simovic-LorenzM. ErnstA. Chromothripsis in cancer.Nat. Rev. Cancer2025252799210.1038/s41568‑024‑00769‑5 39548283
     [Google Scholar]
  18. VoroninaN. WongJ.K.L. HübschmannD. The landscape of chromothripsis across adult cancer types.Nat. Commun.2020111232010.1038/s41467‑020‑16134‑7 32385320
     [Google Scholar]
  19. HockenberyD. NuñezG. MillimanC. SchreiberR.D. KorsmeyerS.J. BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death.Nature1990348629933433610.1038/348334a0 2250705
     [Google Scholar]
  20. TsujimotoY. FingerL.R. YunisJ. NowellP.C. CroceC.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.Science198422646781097109910.1126/science.6093263 6093263
     [Google Scholar]
  21. BergerS. Computationally designed high specificity inhibitors delineate the roles of BCL-2 family proteins in cancer.Elife20165e2035210.7554/eLife.20352 27805565
     [Google Scholar]
  22. KuB. LiangC. JungJ.U. OhB.H. Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX.Cell Res.201121462764110.1038/cr.2010.149 21060336
     [Google Scholar]
  23. RezaeianzadehO. AsghariS. TajbakhshM. KhalilpourA. ShityakovS. Synthesis and application of diazenyl sulfonamide-based schiff bases as potential BRCA2 active inhibitors against MCF-7 breast cancer cell line.Sci. Rep.2025151666110.1038/s41598‑025‑91113‑w 39994448
     [Google Scholar]
  24. DuttaK. KravtsovV. OleynikovaK. RuzovA. SkorbE.V. ShityakovS. Analyzing the effects of single nucleotide polymorphisms on hnRNPA2/B1 protein stability and function: Insights for anticancer therapeutic design.ACS Omega2024955485549510.1021/acsomega.3c07195 38343990
     [Google Scholar]
  25. PengH. YaoF. ZhaoJ. Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials.Exploration2023322022011510.1002/EXP.20220115 37324035
     [Google Scholar]
  26. TengX. DaiY. LiJ. Methodological advances of bioanalysis and biochemical targeting of intracellular G‐quadruplexes.Exploration2022222021021410.1002/EXP.20210214 37323879
     [Google Scholar]
/content/journals/cddt/10.2174/0115701638381646250523115445
Loading
Breaking Boundaries in Cancer Therapy: Harnessing Chromothripsisinduced Mutations for Targeted Bcl-2 Protein Destabilization
Current Drug Discovery Technologies 23, E15701638381646 (2026); https://doi.org/10.2174/0115701638381646250523115445
/content/journals/cddt/10.2174/0115701638381646250523115445
/content/journals/cddt/10.2174/0115701638381646250523115445
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): apoptosis; BCL-2; cancer therapy; Chromothripsis; ergodic therapy; mutation impact; protein modeling

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test